Documentos relacionados

1. Daratumumab for antibody-mediated rejection: Is it time to target the real culprit?
2. The role of anticomplement therapy in the management of the kidney allograft.
3. Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists.
4. Immunologic and Infectious Concerns in Uterus Transplantation.
5. Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry.
6. Allorecognition and the spectrum of kidney transplant rejection.
7. Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death.
8. Update on current and potential application of extracellular vesicles in kidney transplantation.
9. Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection.
10. Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.